Paul Hastings LLP advised Bank of America and the other joint lead arrangers. Wood Mackenzie announced its $1.465 billion refinancing of its credit facilities. Wood Mackenzie empowers...
Wood Mackenzie’s $1.465 Billion Refinancing
PepGen’s $80.1 Million Offering
Paul Hastings LLP advised Leerink Partners on the matter. PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the...
Primary Wave Music’s Partnership with Nas Nuvens Catalog
Paul Hastings LLP, Souto Correa and Lefosse advised Primary Wave Music, while Simpson Thacher & Bartlett LLP and Mello Torres were counsel to Nas Nuvens. Primary...
American Homes 4 Rent’s $600 Million Green Bond Offering
Paul Hastings LLP advised the underwriters. American Homes 4 Rent (NYSE: AMH) announced that its operating partnership, American Homes 4 Rent, L.P. (the “Operating Partnership”), has...
Skye Bioscience’s $50.25 Million Private Placement
Paul Hastings LLP advised the lead placement agent and the placement agent. Skye Bioscience, Inc. (OTCQB: SKYE), a clinical stage biotechnology company focused on the discovery,...
Biovian’s Partnership with 3P Biopharmaceuticals
Paul Hastings (Europe) LLP, Strelia, Garrigues and Castrén & Snellman advised Keensight Capital on the matter. Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development...
Altice USA’s $2.05 Billion Guaranteed Notes Offering
Ropes & Gray has advised Altice USA, while Paul Hastings LLP advised Goldman Sachs. Altice USA (NYSE:ATUS) issued $2.05 billion Senior Guaranteed Notes due 2029 by its...
sbe and Wyndham’s Launch of New Lifestyle Hotel Brand HQ Hotels & Residences
Paul Hastings LLP advised lifestyle hospitality group sbe in connection with the launch of lifestyle brand HQ Hotels & Residences. sbe, the privately-held leading international lifestyle...
Surgery Partners’ $2.1 Billion Refinancing
Ropes & Gray represented Surgery Partners Inc. in the deal. Paul Hastings LLP advised Jefferies and other joint lead arrangers. Surgery Partners Inc. (NASDAQ:SGRY), a short-stay...
Esperion Therapeutics’ $85.1 Million Public Offering
Paul Hastings LLP advised Jefferies LLC as sole book running manager in connection with Esperion Therapeutics, Inc.’s offering. Esperion Therapeutics, Inc. announced the pricing of its...
Kyverna Therapeutics’ $319 Million Upsized IPO
Paul Hastings advised Kyverna Therapeutics in connection with the company’s upsized initial public offering. Kyverna Therapeutics, Inc., a patient-centered clinical-stage biopharmaceutical company focused on developing cell...
Welsh, Carson, Anderson & Stowe’s Acquisition of EquiLend
Kirkland & Ellis advised Welsh, Carson, Anderson & Stowe on the transaction, and Paul Hastings advised Equilend. Welsh, Carson, Anderson & Stowe (WCAS) announced it entered into...